Sequenom's Revenues, Net Loss Increase in Q4 | GenomeWeb
This article has been updated to include comments from the firm's conference call.
NEW YORK (GenomeWeb News) – Sequenom reported Wednesday that its fourth-quarter revenues rose 41 percent, due primarily to increased placements of its MassArray systems, while its net loss widened 28.3 percent on an increase in expenses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.